Bayesian Capital Management’s Braskem BAK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-23,294
Closed -$150K 688
2024
Q2
$150K Buy
+23,294
New +$185K 0.02% 632
2024
Q1
Sell
-14,094
Closed -$124K 780
2023
Q4
$124K Buy
+14,094
New +$108K 0.01% 644

Other funds holding BAK

Bayesian Capital Management's BAK Position: Q3 2024 in Review

Bayesian Capital Management sold out of Braskem (BAK) in Q3 2024, closing a stake of 23,294 shares — an estimated $150K sold.

Bayesian Capital Management first reported a position in BAK in Q4 2023 and held it in 2 quarters. The position peaked at $150K in Q2 2024. 64 funds tracked by Wall St. Rank hold BAK as of Q3 2024.

  • Bayesian Capital Management reported no remaining Braskem position as of Q3 2024 after selling out during the quarter.
  • Bayesian Capital Management sold 23,294 Braskem shares in Q3 2024, an estimated $150K.
  • Bayesian Capital Management first reported a position in Braskem in Q4 2023 and held it in 2 quarters.
  • Bayesian Capital Management's Braskem position peaked at $150K in Q2 2024.
  • 64 funds tracked by Wall St. Rank held Braskem as of Q3 2024.

Based on Bayesian Capital Management's 13F filing for Q3 2024, filed 14 Nov 2024.